This announcement is a separate document:
康諾亞-B：自願性公告 CM310治療慢性鼻竇炎伴鼻息肉的III期臨床試驗達到主要終點
KEYMED BIO-B: VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF CM310 FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ACHIEVED PRIMARY ENDPOINTS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.